These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 24201389)
1. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009. Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389 [TBL] [Abstract][Full Text] [Related]
2. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer. Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer. Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690 [TBL] [Abstract][Full Text] [Related]
5. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma. Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848 [TBL] [Abstract][Full Text] [Related]
6. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy. Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608 [TBL] [Abstract][Full Text] [Related]
7. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402 [TBL] [Abstract][Full Text] [Related]
8. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166 [TBL] [Abstract][Full Text] [Related]
9. Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer. Jäger T; Neureiter D; Urbas R; Klieser E; Hitzl W; Emmanuel K; Dinnewitzer A Dis Colon Rectum; 2017 Aug; 60(8):815-826. PubMed ID: 28682967 [TBL] [Abstract][Full Text] [Related]
10. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer. Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995 [TBL] [Abstract][Full Text] [Related]
11. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Eldin NS; Yasui Y; Scarfe A; Winget M Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914 [TBL] [Abstract][Full Text] [Related]
12. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter? Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691 [TBL] [Abstract][Full Text] [Related]
13. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy. Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA; Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947 [TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M J BUON; 2013; 18(2):385-90. PubMed ID: 23818350 [TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
16. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501 [TBL] [Abstract][Full Text] [Related]
17. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer. Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400 [TBL] [Abstract][Full Text] [Related]
18. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only? Reshef A; Lavery I; Kiran RP Dis Colon Rectum; 2012 Jan; 55(1):51-8. PubMed ID: 22156867 [TBL] [Abstract][Full Text] [Related]
20. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E; Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]